Agenus Inc. (AGEN) Fundamentals

Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multiple antibody platforms, to stimulate the immune system to recognize and fight cancer cells. The company has been cooperating with companies like Incyte, Merck Sharpe & Dohme, and Recepta Biopharma to achieve over a dozen antibody programs. Some of its products include Prophage, AutoSynVax, QS-21 Stimulon, and others.
SHARE INFORMATION
Market Cap$ 801,654,732
Shares Outstanding304,811,685
Float289,438,631
Percent Float94.96%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 295,664,000
Latest Fiscal EPS$ -0.21
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions331
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months20,886,468
Institutional Holdings Percent80.3%
Institutional Sold Previous 3 Months19,913,544
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months34,397
Insider Holdings Percent2.8
Insider Sold Previous 3 Months-
Insider Shares Owned7,975,641
TRADING INFO
52 Week High$ 3.62
52 Week Low$ 1.25
52 Week High Change$ -16.51
21 Day Moving Average$ 2.699
21 Day Extended Moving Average$ 2.757
50 Day Moving Average$ 2.5388
50 Day Extended Moving Average$ 2.6395
200 Day Moving Average$ 2.3953
200 Day Extended Moving Average$ 2.6673
10 Day Average Volume4,524,909
20 Day Average Volume5,315,080
30 Day Average Volume4,870,116
50 Day Average Volume4,958,979
Alpha0.006440
Beta1.3021
Standard Deviation0.226460
R20.092685
7 Day Price Change$ -0.41
7 Day Percent Change-13.49%
21 Day Price Change$ 0.40
21 Day Percent Change17.94%
30 Day Price Change$ 0.08
30 Day Percent Change3.14%
Month to Date Price Change$ 0.12
Month to Date Percent Change4.78%
Quarter to Date Price Change$ 0.58
Quarter to Date Percent Change28.29%
180 Day Price Change$ 1.02
180 Day Percent Change63.35%
200 Day Price Change$ 1.00
200 Day Percent Change61.35%
Year to Date Price Change$ -0.59
Year to Date Percent Change-18.32%

Agenus Inc. (AGEN) Key Ratios

PROFITABILITY
EBIT Margin-181.4%
EBITDA Margin-173.9%
Pre-Tax Profit Margin-267.5%
Profit Margin Count0.57%
Gross Margin-303.1%
Profit Margin TOT0.57%
INCOME STATEMENTS
Revenue$ 89,900,000
Revenue Per Share$ 0.2949
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-16.00
Total Debt To Equity23.50
Int Coverage-2.70
Current Ratio1.50
Leverage Ratio62.40
Quick Ratio1.30
Long Term Debt To Capital0.95
VALUATION MEASURES
PE Ratio-3.20
Enterprise Value$ 677,838,315
Price to Sales8.9172
Price to Free Cash-4.00
PE High Last 5 Years-3.10
Price To Book218.60
Price To Cash Flow50.00
PE Low Last 5 Years-2.40
Price to Tangible Book-16.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover17.80
Invoice Turnover0.00
Assets Turnover0.30
Return Assets-56.13
Return on Equity-2,978.48
Return on Capital-210.43

Agenus Inc. (AGEN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOGaro H. Armen
Emplyoees441
Last AuditUQ
CIK0001098972
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address3 Forbes Road
Lexington, MA 02421-7305
Websitehttps://www.agenusbio.com
Facsimile+1 781 674-4200
Telephone+1 781 674-4400
Emailinvestor@agenusbio.com


Your Recent History
NASDAQ
AGEN
Agenus
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.